| Tofacitinib studied in …STUDIED_INderived16 of 16show fewer |
|---|
| → studied in | NCT06698822Phase 2 · recruiting A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA · 16 trials list this drug (2 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05326464Phase 3 · completed Tofacitinib in Recurrent GBM Patients · 16 trials list this drug (2 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04431895early Phase 1 · completed Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study · 16 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03976245Phase 4 · recruiting Advanced Therapeutics in Rheumatoid Arthritis (RA) · 16 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04721821completed Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy. · 16 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04034238Phase 1 · completed Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid Tumors · 16 trials list this drug (2 active) | — | — | Epithelioid Mesothelioma,Cholangiocarcinoma,Pancreatic Adenocarcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04798287completed Safety of TofAcitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA)-Cancer Endpoints · 16 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02092467Phase 4 · completed Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis · 16 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01815424Phase 3 · completed A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis · 16 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01186744Phase 3 · completed A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis · 16 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00960440Phase 3 · completed Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors · 16 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03598959Phase 2 · unknown Tofacitinib Combined With Chidamide in R/R ENKTCL · 16 trials list this drug (2 active) | — | — | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01163253Phase 3 · terminated A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis · 16 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01519089Phase 3 · completed A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis · 16 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01276639Phase 3 · completed A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis · 16 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01309737Phase 3 · completed A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis · 16 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |